Guidelines on valvular heart disease
248ESCGuidelines
Table10Anatomicscorespredictingoutcomeafterpercutaneousmitralcommissurotomy:Wilkins’mitralvalvemorphologyscore137Grade12
Mobility
Highlymobilevalvewithonlylea ettipsrestrictedLea etmidandbaseportionshavenormalmobility
Valvecontinuestomoveforwardindiastole,mainlyfromthebaseNoorminimalforward
movementofthelea etsindiastole
SubvalvularthickeningMinimalthickeningjustbelowthemitrallea etsThickeningofchordalstructuresextendingtoone-thirdofthechordallength
ThickeningextendedtodistalthirdofthechordsExtensivethickeningandshorteningofallchordalstructuresextendingdowntothepapillarymuscles
Thickening
Lea etsnearnormalinthickness(4–5mm)Mid-lea etsnormal,
considerablethickeningofmargins(5–8mm)Thickeningextendingthroughtheentirelea et(5–8mm)
Considerablethickeningofalllea ettissue(.8–10mm)
Calci cation
Asingleareaofincreasedechobrightness
Scatteredareasofbrightnesscon nedtolea etmargins
3
Brightnessextendingintothemid-portionsofthelea etsExtensivebrightness
throughoutmuchofthelea ettissue
4
Table11Anatomicscorespredictingoutcomeafterpercutan-eousmitralcommissurotomy:Cormier’sgradingofmitralvalveanatomy142
EchocardiographicgroupGroup1
Mitralvalveanatomy
Pliablenon-calci edanteriormitrallea etandmildsubvalvulardisease(i.e.thinchordae 10mmlong)Pliablenon-calci edanteriormitrallea etandseveresubvalvulardisease(i.e.thickenedchordae,10mmlong)Calci cationofmitralvalveofanyextent,asassessedby uoroscopy,whateverthestateofsubvalvularapparatus
Group2
Group3
Clinicalfollow-updatacon rmthelateef cacyofPMCsinceevent-freesurvivalrangesfrom35to70%after10–15years,dependingonpatientcharacteristics.135,144,145Whentheimmediateresultsareunsatisfactory,surgeryisusuallyrequiredinthefollowingmonths.Conversely,aftersuccessfulPMC,long-termresultsaregoodinthemajorityofcases.Whenfunctionaldeteriorationoccurs,itislateandmainlyrelatedtore-stenosis.SuccessfulPMChasalsobeenshowntoreduceembolicrisk.Thepredictionoflong-termresultsisrelatedtopreoperativeanatomicandclinicalcharacteristicsandtothequalityoftheimmediateresults.135,145Identi cationofthevariableslinkedtooutcomehasenabledpredictivemodelstobedevelopedwithahighsensitivity;however,theirspeci cityislow,indi-catinginsuf cientpredictionofpoorimmediateresults.Surgery
Conservativesurgery
Inindustrializedcountries,closedmitralvalvecommissurot-omyhasbeenreplacedbyopen-heartmitralcommissurot-omyusingcardiopulmonarybypass,whichnotonlycorrectscommissuralfusionbutalsoactsonsubvalvulardeformity.Inselectedseriesfromexperiencedcentres,mostlyincludingyoungpatients,long-termresultsaregood:at15years,survivalwas96%,andfreedomfromvalve-relatedcomplications92%.146TherecentEuroHeartSurveyshowsthatincurrentpractice,open-heartcommis-surotomyisseldomperformed.3
Valvereplacement
Operativemortalityrangesbetween3and10%andcorre-lateswithage,functionalclass,pulmonaryhypertension,andpresenceofcoronaryarterydisease.Long-termsurvivalisrelatedtoage,functionalclass,atrial brillation,pulmonaryhypertension,preoperativeLVfunction,andcomplicationsoftheprostheticvalve,especiallythrombo-embolismandhaemorrhageorstructuraldeterioration.147
Echocardiographyalsoplaysanimportantroleinmonitor-ingtheresultsofPMCduringtheprocedureandinevaluat-ingthe nalresultsatleast24hafteritscompletion.
Naturalhistory
Studiesonnaturalhistoryareoldandnon-controlled.Inasymptomaticpatients,survivalwasgoodupto10years,progressionbeinghighlyvariablewithsuddendeterioration,precipitatedbycomplications,suchasatrial brillationorembolism,inhalfofthepatients.140,141Symptomaticpatientshaveapoorprognosis.
Resultsofintervention
Percutaneousballooncommissurotomy
PMCusuallyprovidesatleasta100%increaseinvalvearea.Goodinitialresultsareusuallyde nedbyavalvearea.1.5cm2withoutmorethanmildMR.Technicalsuccessandcomplicationsarerelatedtotheconditionofthepatientandtheteam’sexperience.142–145Failureratesrangefrom1to15%.Majorcomplicationsratesareasfollows:proceduralmortality,0.5–4%;haemopericardium,0.5–10%;embolism,0.5–5%;severeregurgitation,2–10%.Emergencysurgeryisseldomneeded(,1%).
Indicationsforintervention
Typeoftreatment,aswellasitstiming,shouldbedecidedonthebasisofclinicalcharacteristics(includingfunctionalstatusandpredictorsofoperativeriskandoftheresultsofPMC),
Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...
Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...
2006年: ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (美国) ? 2007年:ESC Guidelines on the Management of Valvular Heart...
VALVULAR HEART DISEASE 52页 7下载券 Valvular Heart Disease 暂无评价 87页 1下载券 2007:ESC:Guidelines ... 39页 1下载券 A403-A418 Valvular Hea... 16...
No part of the ESC Guidelines may be translated or reproduced in any form..., Working Group on Thrombosis, Working Group on Valvular Heart Disease. ...
10.1093/eurheartj/ehr218 ESC GUIDELINES ESC Guidelines on the management ...Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac...
Guidelines on the prevention, diagnosis, and ...(ESCMID) and the International Society of ...on valvular heart disease: focused update on ...
10.1093/eurheartj/ehu281 ESC GUIDELINES 2014 ESC Guidelines on the ...and Cardiac Computed Tomography, Peripheral Circulation, Valvular Heart Disease....
European Heart Journal doi:10.1093/eurheartj/ehs104 ESC GUIDELINES ESC ...Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...
Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...No part of the ESC Guidelines may be translated or reproduced in any form...
热门文档